logo
Select company
Select metric
$ 740.2KStock Based Compensation
VS
Market
82
Sector
86
Industry
87
History
36
$ 0.38Close
$ 0.17 - $ 1.41 52-Week Range
Ticker Information

Ticker

PCSA

Company Name

PROCESSA PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PROCESSA PHARMACEUTICALS INC - Stock Based Compensation Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PCSA - SB Comp. Historical data
DateStock Based Compensation
6/30/2025$ 740.2K
3/31/2025$ 689.58K
12/31/2024$ 629.51K
9/30/2024$ 731.28K
6/30/2024$ 719.99K
3/31/2024$ 886.48K
12/31/2023$ 1.06M
9/30/2023$ 3.58M
6/30/2023$ 6.65M
3/31/2023$ 8.34M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Stock Based Compensation

[Cash Flow Statement] Stock Based Compensation, also called Share Based Compensation or Equity Compensation, is a method of paying directors, executives and employees with equity in the business. As non-cash expense, this element is added back when calculating net cash generated by operating activities [NCFO].

PCSA - Stock Based Compensation, Last 5 years

$ 473.35K

Minimum

Sep 30, 2020

$ 8.83M

Maximum

Dec 31, 2022

$ 3.35M

Average

$ 3.17M

Median

SB Comp. Benchmark Analysis

The chart above depicts the distribution of SB Comp. for companies in the Total Stock Market. The average SB Comp. of the companies is $ 12.15M with a standard deviation of $ 14.38M.
The following table provides additional summary stats:
SB Comp. in the Market:
filtered constituents3.51K
min$ -20.28M
max$ 59.43M
average$ 12.15M
median$ 6.38M
std$ 14.38M